Your browser doesn't support javascript.
loading
The anti-obesity effect of rimonabant is associated with an improved serum lipid profile.
Poirier, B; Bidouard, J-P; Cadrouvele, C; Marniquet, X; Staels, B; O'Connor, S E; Janiak, P; Herbert, J-M.
Affiliation
  • Poirier B; Cardiovascular-Thrombosis Department, Sanofi-Synthélabo Research, 91835 Chilly-Mazarin Cedex, France. bruno.poirier@sanofi-synthelaboc.om
Diabetes Obes Metab ; 7(1): 65-72, 2005 Jan.
Article in En | MEDLINE | ID: mdl-15642077
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrazoles / Anti-Obesity Agents / Lipids / Obesity Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2005 Document type: Article Affiliation country:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrazoles / Anti-Obesity Agents / Lipids / Obesity Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2005 Document type: Article Affiliation country: